Otros idiomas Zai Lab Limited

Acciones

ZLAB

US98887Q1040

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
15,91 ^USD	+1,08 %		+13,08 %	-41,79 %

17/04	La renta variable asiática negociada en EE.UU. como recibos de depósito estadounidenses se mantiene plana en la sesión del miércoles	MT
11/04	La consejera delegada de Zai Lab y otros "no prevén" vender acciones de la empresa en lo que queda de 2024	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading	17/04
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024	15/04
Zai Lab Statement on Executive Management Team's Agreement on Share Activities	12/04
Zai Lab CEO, Others 'Do Not Anticipate' Selling Company Shares in Remainder of 2024	11/04
Zai Lab Statement on Executive Management Team’s Agreement on Share Activities	11/04
Zai Lab Changes Record Date	11/04
Zai Lab Grants Share Options, Restricted Share Units to Eligible Personnel	05/04
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI Meets Primary Endpoint	02/04
Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs	02/04
Bristol-Myers Squibb Therapy for Pretreated Non-Small Cell Lung Cancer Meets Primary Endpoint	01/04
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...	01/04
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases	28/03
Zai Lab Reports Lesser Loss in 2023	28/03
Zai Lab, Novocure Say TTFields Therapy Delays Intracranial Progression in Non-Small Cell Lung Cancer Brain Metastases Patients	27/03
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer	27/03
Zai Lab Partner Novocure Announces Metis Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating A Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer	27/03
Asian Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading	20/03
Asian Equities Traded in the US as American Depositary Receipts End Week Lower in Friday Trading	15/03
Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors	14/03
Zai Lab Limited to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate for Treatment of Solid Tumors	14/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Zai Lab Limited

Acciones

ZLAB

US98887Q1040

Otros idiomas

Filtros